RayVa((TM)) Phase 2a Trial Top-Line Data Expected in Third Quarter
Fispemifene Phase 2b Trial in Symptomatic Secondary Hypogonadism Enrolling on
Schedule
Recent Launches in Europe More than Double Vitaros(®) Quarterly Unit Sales
Conference ...
↧